Thirdly, due to the fact that the study population consists entirely of Asians, the results reflect the situation regarding the use of MAO-B inhibitors in combination with levodopa for treating motor fluctuations in Parkinson’s disease patients within this ethnic group, and therefore, the findings may not be generalizable to other ethnic populations. The gene discussed is MAOB; the disease is Parkinson disease.